Accelerating access to precision oncology with decentralized MSK solutions

SOPHiA GENETICS is collaborating with Memorial Sloan Kettering Cancer Center (MSK) to decentralize their advanced precision oncology tools – MSK-ACCESS® for liquid biopsy and MSK-IMPACT® for comprehensive genomic profiling (CGP). By combining the clinical expertise of MSK in cancer genomics, the predictive algorithms of SOPHiA DDM™, and the power of the global SOPHiA GENETICS network, experts hope to expand access to precision cancer analysis capabilities worldwide.

Presented by:
Michael F. Berger, PhD, Co-Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology, Elizabeth and Felix Rohatyn Chair for Junior Faculty
Chloe Ryder, Product Manager at SOPHiA GENETICS

Sign Up To View The Webinar

First Name

Last Name

Institution

Job Title

Area of Interest

Phone

Country

Primary Focus I am interested in somatic solutionsI am interested in germline solutions

Comments

Privacy Policy I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. View our Privacy Policy for more information.

Pardot Opt-in I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

Comments